BEIJING -- China's vaccine diplomacy faces a setback as questions arise about the efficacy and safety of its coronavirus inoculations while the country speeds a large-scale rollout despite the candidates remaining in the clinical trial phase.
Coronavirus
China slips in COVID-19 vaccine race on doubts over effectiveness
Xi made inoculation diplomacy a key part of global strategy
A Sinovac production line for the coronavirus vaccine at its Beijing site. (Photo by Shin Watanabe)
Read Next
Latest on Coronavirus
